A detailed history of S Bank Fund Management LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, S Bank Fund Management LTD holds 1,299 shares of EXAS stock, worth $69,366. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,299
Holding current value
$69,366
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$43.04 - $58.51 $55,908 - $76,004
1,299 New
1,299 $56.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.45B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track S Bank Fund Management LTD Portfolio

Follow S Bank Fund Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S Bank Fund Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on S Bank Fund Management LTD with notifications on news.